AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06041243 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Game-Based Exercises
Description: Exercises aimed to improve postural balance with four different games
Study NCT06477367 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video-Based Breathing Exercises
Description: Researchers will present a 5-7 minute instructional video aimed at helping participants recall the technique for performing the exercises. These instructional videos will be sent to the researchers' mobile phones via WhatsApp. Participants will be instructed to perform the exercises three times a day for 15 minutes each, for a period of 30 days. To encourage regular exercise, participants will be provided with an exercise diary, and researchers will send reminder SMS messages at the same time every day. The control group will receive the clinic's routine dyspnea care protocol. After thirty days, final tests will be administered to both groups, and the research will be concluded.
Study NCT06112613 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Health Record Review
Description: Ancillary studies
Study NCT06112613 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Promotion and Education
Description: Receive access to educational materials
Study NCT06112613 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Health Telemonitoring
Description: Utilize the WiseBag medication dispenser
Study NCT06112613 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Complete an interview
Study NCT06112613 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Navigation
Description: Receive healthcare provider follow ups as part of the CONCURxP program
Study NCT06112613 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study NCT06112613 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Text Message-Based Navigation Intervention
Description: Receive personalized text message reminders related to their medication tracking as part of the CONCURxP program
Study NCT06435949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl (as Citrate)
Description: intravenous anesthesia with propofol with fentanyl (group Fentanyl) and propofol with oxycodone (group Oxycodone)
Study NCT04958928 — intervention group
Intervention type: PROCEDURE
Intervention: Catheter ablation
Description: All patients received radiofrequncy ablation.
Study NCT05342740 — intervention group
Intervention type: OTHER
Intervention: collect whole blood, urine and stool samples
Description: collect whole blood, urine and stool samples
Study NCT06362343 — intervention group
Intervention type: DRUG
Intervention: Rivaroxaban
Description: Rivaroxaban
Study NCT05905887 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivoceranib Mesylate, Paclitaxel
Description: Paclitaxel will be administered at 80mg/m2/day every four weeks at Day 1, Day 8 and Day 15 per cycle. One cycle consists of 4 weeks (28 days).~Rivoceranib 400 mg orally once a day.
Study NCT05634447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug: CKD-391, QD, PO
Description: Drug: CKD-331, D337 QD, PO
Study NCT05302453 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Basic Body Awareness Therapy
Description: Basic Body Awareness Therapy (BBAT), which is among the body-mind approaches, is also frequently used in the rehabilitation of patients with psychiatric disorders, pain, and chronic musculoskeletal system problems.
Study NCT05261945 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine Physical Therapy
Description: Routine Physical Therapy treatment with hot pack, TENS, and ultrasound helps in improving and relaxing the muscle spasm and soft tissue elasticity along pain reduction.
Study NCT05261945 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual Therapy And Routine Physical Therapy
Description: Mulligan is consider one of the most effective technique of mobilization.it is also important treatment for neck pain so that many physiotherapist used mulligan by including several methods such as Natural Apophyseal Glides or Sustained Natural Apophyseal Glides.
Study NCT05261945 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching Exercises And Routine Physical Therapy
Description: Regular stretching helps increase your range of motion in the joints, improves blood circulation and posture and alleviates muscular tension throughout the body.
Study NCT06153888 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrafiltration rate
Description: Fluid removal during HD will be linear. The time on HD for fluid removal is adjusted after a formula for interdialytic weight gain / removal time (see Goto et al 2023).
Study NCT06153888 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrafiltration rate
Description: Fluid removal during HD will be linear. The time on HD for fluid removal is adjusted after a formula for interdialytic weight gain / removal time (see Goto et al 2023).
Study NCT05075447 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotion Control Treatment Program
Description: Intervention programs include Child Training and Training in real scenes
Study NCT06420258 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Deeper endotracheal intubation
Description: After general anesthesia, endotracheal intubation was conducted using an ultrafine endoscope (GIF-XP260NS, Olympus Corp., Japan), which allows observation of the exact position and avoids blindness caused by laryngoscopy. To prevent balloon compression of the CE after inflating, the endotracheal intubation tube was inserted above the tracheal carina, roughly the upper thoracic esophagus.
Study NCT05853731 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Green light emitting diode
Description: Green light therapy via light emitting diode (LED) in the 520 nanometers (nm) range at 4 lux intensity for up to 5 hours per day, as tolerated.
Study NCT05853731 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: White light emitting diode
Description: Filtered white light via light emitting diode (LED) displayed for up to 5 hours per day, as tolerated
Study NCT06284629 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neptune
Description: Neptune is a software algorithm that utilizes data from wrist-worn sensors to track Parkinson motor symptoms and displays them in an easy to understand graph. Neptune Care is a mobile app that includes a patient portal, where patients can self-report symptoms, view their motor data and get medication reminders, and a physician portal, where the treating physician can view the objective motor data and patient-reported outcomes prior to a clinical visit.
Study NCT06284629 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard clinical care
Description: Treatment and management according to standard clinical care
Study NCT05594615 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EDP-235
Description: Subjects will receive EDP-235 once daily on Days 5-15
Study NCT05594615 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Subjects will receive midazolam once daily on Days 1 and 12
Study NCT04683302 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3DUS biplanar catheterization
Description: biplanar view of both short and long axis view of the internal jugular vein improves anatomical awareness and potentially improves safety of venous catheterization
Study NCT04683302 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 2D US catheterization
Description: 2D short axis internal jugular vein catheterization
Study NCT05594615 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Subjects will receive rosuvastatin once daily on Days 2 and 13
Study NCT05594615 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caffeine
Description: Subjects will receive caffeine once daily on Days 1 and 12
Study NCT06505720 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Arthroscopic management of acute pediatric septic hip infecion
Description: Three-portals tractionless hip arthroscopy will be used to treat acute pediatric septic hip infection
Study NCT06505720 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Open debridement of acute pediatric septic hip
Description: surgical drainage and debridement of acute septic hip in children via classic lateral approach
Study NCT05863598 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhancing protective factors
Description: Participants will watch some short movies and infographics, and will be asked to argue for the importance of body image flexibility, body functionality appreciation, etc.
Study NCT05863598 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Expressive writing
Description: Participants will reflect and write about any cognitions or emotions they can have in relation to their bodies.
Study NCT05530018 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief contact intervention
Description: The brief contact intervention (BCI) will send out text messages to the participants. The text messages will include caring messages, reminders of appointments, and a link to a web page. The web page is anticipated to include safety planning, volitional helpsheet, and resources information. The text messages are anticipated to send out to the participants on a weekly base for 6 weeks in a row, and then change to monthly reminders. The monthly reminders are anticipated to include caring messages, reminders of appointments, and invitations to encourage the participants to click the previous web links again. The monthly reminders are anticipated to send out to the participants three times in a row. In the final reminder, the participants will be told that this intervention is going to end. In total, the participants will receive 9 texts within 5 months.
Study NCT04840836 — intervention group
Intervention type: BEHAVIORAL
Intervention: Telehealth-supported LARC provision
Description: Provision of LARC in routine care will include a hybrid model of telehealth-supported long-acting reversible contraception (LARC) service provision in a network of 6 school-based health centers (SBHCs) in New York City that serve adolescents and young adult high school students age 13-22 years (hereafter referred to as adolescents).
Study NCT05694221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Supaglutide injection
Description: Administered subcutaneously in the Supaglutide arms
Study NCT05694221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin
Description: Oral Administration
Study NCT05694221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Oral Administration
Study NCT04845529 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation (tDCS)
Description: We will apply tDCS to the patients' brains for 20 minutes at the intensity of 1.5mA. Each patient will undergo the three sessions (separated by at least 24h to minimize carry-over effects), in a pseudo-randomized order across patients.
Study NCT04845529 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Description: We will apply tDCS to the patients' brains for 20 minutes at the intensity of 1.5mA. Each patient will undergo the three sessions (separated by at least 24h to minimize carry-over effects), in a pseudo-randomized order across patients.
Study NCT04785690 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CureSight
Description: Subjects assigned to the binocular treatment group will be prescribed the CureSight treatment to watch for 90 minutes per day, 5 days a week for 16 weeks for the total of 120 hours. Parents of subjects will be instructed that the 90 minutes of daily treatment should be completed in a single 90-minute session, but if this is not possible for whatever reason, the treatment may be divided into two shorter sessions totaling 90 minutes per day
Study NCT04785690 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Patching
Description: Subjects assigned to the patching group will wear an adhesive patch over the dominant eye for 2 hours per day, 7 days per week for 16 weeks. Parents of subjects will be instructed that the 2 hours of daily patching should be completed in a single 2-hour session, but if this is not possible for whatever reason, the treatment may be divided into shorter sessions totaling 2 hours.~Parents will be asked to complete a usage diary by manually recording the patch usage time on daily basis.
Study NCT05112276 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diet
Description: A review has been undertaken to both identify specific bacteria associated with cardiometabolic risk factors and food items that have been shown to affect such bacteria in a beneficial direction. The intervention diet will include a variety of food items e.g. vegetables, fermented vegetables, fermented dairy products and cereal products. The control diet is based on a Swedish Average Diet
Study NCT05112276 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet
Description: A review has been undertaken to both identify specific bacteria associated with cardiometabolic risk factors and food items that have been shown to affect such bacteria in a beneficial direction. The intervention diet will include a variety of food items e.g. vegetables, fermented vegetables, fermented dairy products and cereal products. The control diet is based on a Swedish Average Diet
Study NCT05545280 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine with glycopyrrolate
Description: Administration by intravenous infusion
Study NCT05545280 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sugammadex
Description: Administration by intravenous infusion
Study NCT05307367 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: Patients will be enrolled in a 8 week, supervised, single-leg kicking training intervention (1h, or as long as possible, 60-70% peak workload (PWL), 2-5 days a week). Healthy age-, body weight-, gender- and activity level-matched control subjects will undertake the intervention matched to the %PWL obtained by the patients who complete the study.
Study NCT06425627 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: spinal anesthesia
Description: An intrathecal anesthetic technique.
Study NCT06425627 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: general anesthesia
Description: An intravenous (combined with inhalation) anesthetic technique.
Study NCT04745260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intranasal Fentanyl Spray and Intranasal Midazolam Spray
Description: Intranasal Fentanyl 2mcg/kg and Intranasal Midazolam 0.2mg/kg
Study NCT04745260 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intranasal Midazolam Spray
Description: Intranasal Midazolam 0.3mg/kg
Study NCT04694586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rifampicin
Description: rifampicin 35 mg/kg
Study NCT04694586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pyrazinamide
Description: pyrazinamide 40 mg/kg
Study NCT04694586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRZE
Description: isoniazid 75 mg + rifampicin 150 mg + pyrazinamide 400 mg + ethambutol 275 mg combination tablets
Study NCT04694586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR
Description: isoniazid 75 mg + rifampicin 150 mg combination tablets
Study NCT04817917 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Japanese Encephalitis Vaccine (Vero Cell), Inactivated;
Description: The investigators recruit 6 years old children who have been vaccinated by 2-3 doses of JE vaccines with different immunization strategies. For participants from Group 1 and Group 2 who haven't completed the JE immunization schedules, a booster dose of JEV-I will be administered at 6 years old.
Study NCT05402384 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVTX-801
Description: Medical grade D-galactose~dosage:2.0 g/kg/day
Study NCT05402384 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: AVTX-801
Description: Medical grade D-galactose~dosage:2.0 g/kg/day
Study NCT04817917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No prospective interventions
Description: The investigators recruit 6 years old children who have been vaccinated by 2-3 doses of JE vaccines with different immunization strategies. Participants from Group 3-5 have completed the JE immunization schedules with JEV-I or/and JEV-L. No prospective intervention will be given.
Study NCT06545396 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Half-dose illumination protocol
Description: Area will be treated according to the classic protocol, in a single session. First, the surface of the actinic keratoses will be scraped to remove scales and crusts. Using a spatula, a sufficient amount of photosensitizing cream will be applied to cover the treatment area (1 mm thick). The treated area will then be covered with an occlusive dressing for 3 hours. After this interval, the dressing will be removed and the area will be exposed to a red light source for 8 minutes with a spectrum of 630 nm and 18,5J/cm2, with the illumination intensity being less than 200 mW/cm2.
Study NCT06545396 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Full-dose illumination protocol
Description: Area will be treated according to the classic protocol, in a single session. First, the surface of the actinic keratoses will be scraped to remove scales and crusts. Using a spatula, a sufficient amount of photosensitizing cream will be applied to cover the treatment area (1 mm thick). The treated area will then be covered with an occlusive dressing for 3 hours. After this interval, the dressing will be removed and the area will be exposed to a red light source for 8 minutes with a spectrum of 630 nm and 37J/cm2, with the illumination intensity being less than 200 mW/cm2.
Study NCT05853874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutrition intervention (dietary protocol)
Description: The nutrition intervention sought to improve participants' overall diet quality, taking into account a sufficient intake of carbohydrates, lipids, fibres and micronutrients (vitamins and minerals), promoting proper fruits and vegetables consumption and variety. About water intake, considering the high dehydration risk in older persons highlighted by the European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines, its adequate consumption is recommended and encouraged.
Study NCT05853874 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Hospital standard of care
Description: The standard clinical procedures following the malnutrition diagnoses will be implemented according to the routine of the two hospitals
Study NCT05402384 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo
Study NCT05402384 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study NCT06334367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD25 treatment
Description: CD25 prophylaxis
Study NCT06334367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: low-dose ATG
Description: HSCT pre-treatment with 7.5mg/Kg ATG(2.5mg/Kg/d) at day -4, -3 and -2.
Study NCT06334367 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: low-dose ATG
Description: HSCT pre-treatment with 7.5mg/Kg ATG(2.5mg/Kg/d) at day -4, -3 and -2.
Study NCT05863715 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visual Search Cue Type
Description: Participants receive a target color cue (positive), a distractor color cue (negative), or a neutral non-informative cue prior to visual search.
Study NCT05789992 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Propofol (Random:3-5ug/ml)
Study NCT05789992 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Low Remifentanil
Description: Remifentanil (Random:0-3ug/ml)
Study NCT05789992 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heigh Remifentanil
Description: Remifentanil (Random:3-5ug/ml)
Study NCT05789992 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intubation
Description: Endotracheal intubation before surgery
Study NCT05926375 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HINEX Jelly ( jelly high protein supplement)
Description: In self-controlled phase,which intake 400\~500 kcal breakfast, or in supplement phase consume one servings of jelly high protein supplement (303 kcal, 15 g protein and 2400 mg BCAA per serving) and 100\~200 kcal food at breakfast per day, for 8 weeks.
Study NCT05806489 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intermittent Fasting
Description: Participants received a 3-day individualized diet plan consisting of 3 meals per day. Meals needed to be consumed during 6 hours (while fasting for the remaining 18 hours). Diet plans were matched for energy and macronutrients.
Study NCT05806489 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control Diet
Description: Participants received a 3-day individualized diet plan consisting of 3 meals per day. Meals needed to be consumed during 12 hours (while fasting for the remaining 12 hours). Diet plans were matched for energy and macronutrients.
Study NCT05789992 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: tetanic electrical stimulation
Description: tetanic electrical stimulation before surgery
Study NCT05265780 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: kinesiotape
Description: an elastic adhesive tape
Study NCT05265780 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: sham taping
Description: a sham taping without the tension